Innovative research
Integrated solutions
Comprehensive consultation
The future of healthcare diagnostics & therapeutics
Holburn Biomedical Corporation is a contract research organization that provides customized research and development solutions for the pharmaceutical, biotechnology and diagnostic industries.
Operating at the interface between academic research and commercial scientific development, we provide expert solutions in biomarker development, pathology, physiology, immunology and gastrointestinal diseases.
Our mission is to provide innovative research, integrated solutions and comprehensive consultation, enabling our clients to realize their goals.
-
Laboratory Science
Holburn offers a comprehensive laboratory test menu with specialization in pathology and companion diagnostics. Our scientists also have extensive research and development expertise with models for visceral and somatic pain. We provide technology transfer programs, new technology implementation, assay validation and verification procedures, policy documentation and regulatory compliance solutions.
-
Consulting
Holburn’s team of opinion leaders and research scientists have developed comprehensive consulting solutions, with strategic pathways for clients with pre-clinical and clinical goals. These development programs offer unique approaches to drug and diagnostic device innovation and ensure significantly accelerated and increased market success.
-
Clinical Trials
Holburn collaborates with pharmaceutical industry partners in the design, implementation and management of clinical trials. In addition, Holburn scientists are developing innovative approaches to minimize placebo responses, with the objective of increasing the reliability of clinical trial data, shortening the time to market for new pharmaceuticals and wellness products.
-
Products
Holburn is committed to our strategic vision of growth and profitability, with a focus on novel biomedical R&D programs in the healthcare diagnostic and therapeutic spheres. We conduct leading-edge studies in pathology and gastrointestinal physiology, building an intellectual property (IP) inventory.
With over 25 years of experience in the healthcare diagnostics and therapeutics arenas, we know what it takes to turn a great idea into a successful product.
-
Excellence
At Holburn, we believe in giving 100% to everything we do. That’s why we’re committed to providing the highest quality of products and solutions.
-
Integrity
At Holburn, we believe in doing the right thing — always. That’s why we treat everyone with respect while honouring privacy and confidentiality.
-
Growth
At Holburn, we believe growth is the key to sustainable success and innovation. That’s why we’re committed to ongoing learning and development.
-
Collaboration
At Holburn, we believe we’re better together. That’s why we value collaboration built on trust, teamwork and communication.
Investor Relations
At Holburn, we strive for continuous growth and development by creating partnerships we can build on.
We welcome inquiries from future partners for direct investment and collaboration.
Over 25 years of discovery and innovation
Holburn has been a key player in the healthcare diagnostics and therapeutics arena for more than 25 years. We have built many successful partnerships and performed contract research work in the field of irritable bowel syndrome (IBS) and visceral hypersensitivity for GlaxoSmithKline (GSK), Novartis, Johnson and Johnson (J&J; both Beerse and Springhouse divisions), Solvay, Movetis, Shire and Lexicon; immunology studies for Sanofi Pasteur (including earlier studies conducted for Connaught), Ikaria, Shire and Luitpold Pharma (Luitpold); molecular and cellular pathology for Dynacare (then Gamma-Dynacare) and Keytruda (Merck); and in the pathology test and equipment development arena for Sakura Finetek (Sakura), Agilent (Dako), Cytochroma, Cytokinetics and Panacea Global.
The future of healthcare diagnostics & therapeutics
From early diagnosis to tailored treatment, in the future of healthcare diagnostics and therapeutics, anything is possible.
Join us in shaping the future — contact us to find out how.